Helicobacter pylori (H. pylori) is a common type of bacteria that infects the stomach lining and can lead to various gastrointestinal diseases such as gastritis, stomach ulcers, and cancer. The ...

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach and small bowel. It is often symptomless, but it can increase the risk of ulcers, gastritis, and cancer, all of which can ...

What does an ulcer feel like? Experts say symptoms can range from subtle to intense—here’s what to look out for, say two gastroenterologists. The post 11 Signs of an Ulcer You Should Never Ignore, Say ...

Helicobacter pylori infection is a chronic gastric Gram-negative infection that increases with age worldwide. The prevalence of H. pylori detection appears to decrease in frail patients aged over 85 ...

We believe that the pharmacologic treatment induced remission of the skin lesions by direct control of H. pylori chronic infection; in fact, H. pylori may have triggered or enhanced the vasculitis ...

Helicobacter pylori is a gram-negative bacterium that infects the stomach lining; it can cause gastrointestinal conditions such as gastritis or ulcers and can lead to an increased risk of stomach ...

The global helicobacter pylori diagnostics market revenue was around US$ 581.9 million in 2023 and is estimated to reach US$ 926.3 million by 2032, growing at a compound annual growth rate (CAGR) of 5 ...

IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the ...

DUBLIN--(BUSINESS WIRE)--The "Helicobacter Pylori Infections - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers comprehensive Insight of ...

In a recent study published in Scientific Reports, researchers used the bidirectional Mendelian randomization (MR) method, using Helicobacter pylori infection as the study exposure, to investigate its ...

26 August 2015: Recipharm AB, Stockholm, today announces that it has signed an agreement with Israeli biopharmaceutical company RedHill Biopharma Ltd (TASE/NASDAQ: RDHL) ("RedHill") for the ...